Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C

被引：0
|
作者：
Shivakumar Narayanan
Kerry Townsend
Thomas Macharia
Adrian Majid
Amy Nelson
Robert R. Redfield
Shyam Kottilil
Rohit Talwani
Anu Osinusi
机构：
[1] University of Maryland School of Medicine,Division of Infectious Diseases, Institute of Human Virology
[2] National Institutes of Health,Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases
来源：
Hepatology International | 2014年 / 8卷
关键词：
Sofosbuvir; Ribavirin; HCV monoinfection; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：560 / 566
页数：6
相关论文
共 50 条
  • [21] Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin
    Elisa Biliotti
    Cristiana Franchi
    Martina Spaziante
    Anna Rosa Garbuglia
    Lorenzo Volpicelli
    Donatella Palazzo
    Maurizio De Angelis
    Rozenn Esvan
    Gloria Taliani
    Infection, 2018, 46 : 725 - 727
  • [22] Interferon ALFA-2B (IFN-a2B)/ribavirin compared to consensus interferon (CIFN)/ribavirin in treatment of chronic hepatitis C
    Sjogren, MH
    Holtzmuller, K
    Sjogren, RW
    JOURNAL OF HEPATOLOGY, 2001, 34 : 234 - 234
  • [23] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
  • [24] Blood changes in chronic hepatitis C treatment with Interferon and Ribavirin
    Nechita, Andreea Nicoleta
    Navala, Laura Iulia
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 : 31 - 31
  • [25] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [26] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45
  • [27] Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients
    Bruchfeld, A
    Lindahl, K
    Reichard, O
    Carlsson, T
    Schvarcz, R
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (05) : 316 - 321
  • [28] Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy
    Cure, Sandrine
    Guerra, Ines
    Camma, Calogero
    Craxi, Antonio
    Carosi, Giampiero
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (09) : 678 - 690
  • [29] Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
    Cornberg M.
    Wedemeyer H.
    Manns M.P.
    Current Gastroenterology Reports, 2002, 4 (1) : 23 - 30
  • [30] Interferon-α and ribavirin:: advances in the treatment of chronic hepatitis C
    Zeuzem, S
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (20) : 636 - 642
12345